XML 191 R175.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Reportable segments - Operating Segment Items (Details) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021
Disclosure of operating segments [line items] |  |  |
Revenue | $ 7,467,490 | $ 10,710,578 | $ 2,862,315
Cost of sales | (4,392,436) | (4,973,953) | (1,772,208)
Administrative expenses | (175,765) | (142,644) | (118,893)
Finance expense | (138,402) | (86,651) | (84,626)
Depreciation and amortization expense | (280,787) | (244,458) | (214,239)
Interest in the income of associates and joint ventures accounted for by the equity method | 593 | 20,159 | 11,132
Income before taxes | 2,807,018 | 5,486,496 | 841,221
Income tax expense | (1,876,751) | (1,572,212) | (249,016)
Net income | 930,267 | 3,914,284 | 592,205
Assets | 10,778,837 | 10,819,101 | 7,180,201
Investment accounted for under the equity method | 86,417 | 54,386 | 39,824
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 2,785,385 | 1,757,581 | 152,663
Other Liabilities | 6,301,408 | 5,887,100 | 3,964,230
Impairment loss of financial assets recognized in income | 202 | 3,369 | (235)
Impairment loss of non-financial assets recognized in income | (47,068) | (42,233) | (6,060)
Cash flows from (used in) operating activities | (196,639) | 4,077,595 | 822,520
Cash flows used in investing activities | (1,481,493) | (909,401) | (1,006,943)
Cash flows from (used in) financing activities | 66,261 | (2,002,969) | 1,206,485
Operating segments |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 7,467,490 | 10,710,578 | 2,862,315
Cost of sales | (4,392,436) | (4,973,953) | (1,772,208)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (280,787) | (244,458) | (214,239)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 3,075,054 | 5,736,625 | 1,090,107
Income tax expense | 0 | 0 | 0
Net income | 3,075,054 | 5,736,625 | 1,090,107
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of financial assets recognized in income | 0 | 0 | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Unallocated amounts |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Cost of sales | 0 | 0 | 0
Administrative expenses | (175,765) | (142,644) | (118,893)
Finance expense | (138,402) | (86,651) | (84,626)
Depreciation and amortization expense | 0 | 0 | 0
Interest in the income of associates and joint ventures accounted for by the equity method | 593 | 20,159 | 11,132
Income before taxes | (268,036) | (250,129) | (248,886)
Income tax expense | (1,876,751) | (1,572,212) | (249,016)
Net income | (2,144,787) | (1,822,341) | (497,902)
Assets | 10,778,837 | 10,819,101 | 7,180,201
Investment accounted for under the equity method | 86,417 | 54,386 | 39,824
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 2,785,385 | 1,757,581 | 152,663
Other Liabilities | 6,301,408 | 5,887,100 | 3,964,230
Impairment loss of financial assets recognized in income | 202 | 3,369 | (235)
Impairment loss of non-financial assets recognized in income | (47,068) | (42,233) | (6,060)
Cash flows from (used in) operating activities | (196,639) | 4,077,595 | 822,520
Cash flows used in investing activities | (1,481,493) | (909,401) | (1,006,943)
Cash flows from (used in) financing activities | 66,261 | (2,002,969) | 1,206,485
Specialty plant nutrients |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 913,912 | 1,172,334 | 908,815
Cost of sales | (691,509) | (722,261) | (646,930)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (70,342) | (63,321) | (58,808)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 222,403 | 450,073 | 261,885
Income tax expense | 0 | 0 | 0
Net income | 222,403 | 450,073 | 261,885
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of financial assets recognized in income |  |  | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Iodine and its derivatives |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 892,151 | 754,339 | 437,931
Cost of sales | (355,717) | (282,100) | (240,341)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (53,140) | (53,734) | (41,215)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 536,434 | 472,239 | 197,590
Income tax expense | 0 | 0 | 0
Net income | 536,434 | 472,239 | 197,590
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of financial assets recognized in income |  |  | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Lithium and its derivatives |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 5,180,114 | 8,152,939 | 936,121
Cost of sales | (2,955,669) | (3,636,852) | (494,794)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (124,010) | (88,510) | (65,014)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 2,224,445 | 4,516,087 | 441,327
Income tax expense | 0 | 0 | 0
Net income | 2,224,445 | 4,516,087 | 441,327
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of financial assets recognized in income |  |  | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Industrial chemicals |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 175,223 | 165,200 | 132,011
Cost of sales | (141,351) | (112,247) | (109,067)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (15,232) | (14,724) | (13,743)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 33,872 | 52,953 | 22,944
Income tax expense | 0 | 0 | 0
Net income | 33,872 | 52,953 | 22,944
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of financial assets recognized in income |  |  | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Potassium |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 279,050 | 437,180 | 416,592
Cost of sales | (219,597) | (193,581) | (253,125)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (18,006) | (24,043) | (35,290)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 59,453 | 243,599 | 163,467
Income tax expense | 0 | 0 | 0
Net income | 59,453 | 243,599 | 163,467
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of financial assets recognized in income |  |  | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Other products and services |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 27,040 | 28,586 | 30,845
Cost of sales | (28,593) | (26,912) | (27,951)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (57) | (126) | (169)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | (1,553) | 1,674 | 2,894
Income tax expense | 0 | 0 | 0
Net income | (1,553) | 1,674 | 2,894
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of financial assets recognized in income |  |  | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Reportable segments |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 7,467,490 | 10,710,578 | 2,862,315
Cost of sales | (4,392,436) | (4,973,953) | (1,772,208)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (280,787) | (244,458) | (214,239)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 3,075,054 | 5,736,625 | 1,090,107
Income tax expense | 0 | 0 | 0
Net income | 3,075,054 | 5,736,625 | 1,090,107
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of financial assets recognized in income | 0 | 0 | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Parent |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 7,467,490 |  | 2,862,315
Assets | 8,824,362 | 8,430,376 |
Other Liabilities | 4,383,163 | 3,533,744 |
Parent | Operating segments |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 7,467,490 | 10,710,578 | 2,862,315
Parent | Unallocated amounts |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Parent | Specialty plant nutrients |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 913,912 | 1,172,334 | 908,815
Parent | Iodine and its derivatives |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 892,151 | 754,339 | 437,931
Parent | Lithium and its derivatives |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 5,180,114 | 8,152,939 | 936,121
Parent | Industrial chemicals |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 175,223 | 165,200 | 132,011
Parent | Potassium |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 279,050 | 437,180 | 416,592
Parent | Other products and services |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 27,040 | 28,586 | 30,845
Parent | Reportable segments |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 7,467,490 | 10,710,578 | 2,862,315
Other Operating Segment |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Operating segments |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Unallocated amounts |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Specialty plant nutrients |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Iodine and its derivatives |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Lithium and its derivatives |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Industrial chemicals |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Potassium |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Other products and services |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Reportable segments |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | $ 0 | $ 0 | $ 0

X
- Definition The amount of expenses that the entity classifies as being administrative. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 26 -IssueDate 2023-01-01 -Paragraph 35 -Subparagraph b -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_vi&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 99 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_AdministrativeExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2023-01-01 -Paragraph 93 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 28 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2023-01-01 -Paragraph 93 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard -URIDate 2023-03-23 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2023-01-01 -Paragraph 93 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard -URIDate 2023-03-23 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard -URIDate 2023-03-23 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_Assets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 10 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 50 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_CashFlowsFromUsedInFinancingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 10 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 50 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_CashFlowsFromUsedInInvestingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 10 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 50 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_CashFlowsFromUsedInOperatingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 99 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_CostOfSales
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 28 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 23 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_e&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2023-01-01 -Paragraph B13 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B -URIDate 2023-03-23 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 102 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard -URIDate 2023-03-23 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 99 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard -URIDate 2023-03-23 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 104 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DepreciationAndAmortisationExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfOperatingSegmentsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of costs associated with financing activities of the entity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 82 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_FinanceCosts
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Expired 2023-01-01 -Name IFRS -Number 7 -IssueDate 2023-01-01 -Paragraph 20 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_e&doctype=Standard&book=b -URIDate 2023-03-23 + Details
Name: | ifrs-full_ImpairmentLossOnFinancialAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 23 -Subparagraph h -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 26 -IssueDate 2023-01-01 -Paragraph 35 -Subparagraph b -Clause viii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2023-01-01 -Paragraph 79 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard -URIDate 2023-03-23 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2023-01-01 -Paragraph 81 -Subparagraph c -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard -URIDate 2023-03-23 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2023-01-01 -Paragraph 81 -Subparagraph c -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard -URIDate 2023-03-23 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2023-01-01 -Paragraph B13 -Subparagraph g -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B -URIDate 2023-03-23 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 82 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_IncomeTaxExpenseContinuingOperations
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 24 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2023-01-01 -Paragraph B16 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B16&doctype=Appendix&subtype=B -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 54 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_e&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_InvestmentAccountedForUsingEquityMethod
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2023-01-01 -Paragraph 93 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2023-01-01 -Paragraph 93 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2023-01-01 -Paragraph 93 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard -URIDate 2023-03-23 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 28 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard -URIDate 2023-03-23 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard -URIDate 2023-03-23 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_Liabilities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 18 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2023-01-01 -Paragraph 32 -Subparagraph a -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2023-01-01 -Paragraph 24 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard -URIDate 2023-03-23 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 28 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard -URIDate 2023-03-23 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard -URIDate 2023-03-23 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 12 -IssueDate 2023-01-01 -Paragraph B10 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B -URIDate 2023-03-23 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 17 -IssueDate 2023-01-01 -Paragraph 113 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard -URIDate 2023-03-23 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 81A -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard -URIDate 2023-03-23 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 106 -Subparagraph d -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ProfitLoss
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The profit (loss) before tax expense or income. [Refer: Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 5 -IssueDate 2023-01-01 -Paragraph 33 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 28 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard -URIDate 2023-03-23 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard -URIDate 2023-03-23 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 102 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ProfitLossBeforeTax
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 28 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 23 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 32 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard -URIDate 2023-03-23 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 5 -IssueDate 2023-01-01 -Paragraph 33 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard -URIDate 2023-03-23 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 33 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard -URIDate 2023-03-23 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 34 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard -URIDate 2023-03-23 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2023-01-01 -Paragraph B12 -Subparagraph b -Clause v -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B -URIDate 2023-03-23 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 12 -IssueDate 2023-01-01 -Paragraph B10 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B -URIDate 2023-03-23 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 82 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard -URIDate 2023-03-23 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard -URIDate 2023-03-23 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 102 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_Revenue
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 28 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 23 -Subparagraph g -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 82 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Impairment loss of non-financial assets + References No definition available. + Details
Name: | sqm_ImpairmentLossOfNonFinancialAssets
Namespace Prefix: | sqm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Incorporation of noncurrent assets other than financial instruments , deferred tax assets, net defined benefit assets and rights arising from insurance contracts + References No definition available. + Details
Name: | sqm_IncorporationOfNonCurrentAssetsOtherThanFinancialInstruments
Namespace Prefix: | sqm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_UnallocatedAmountsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_SpecialtyPlantNutrientsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_IodineAndItsDerivativesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_LithiumAndItsDerivativesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_IndustrialChemicalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_PotassiumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_OtherProductsAndServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=ifrs-full_ReportableSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=sqm_OtherOperatingSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |